Cresset Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.3M | Sell |
|
|||||
|
2025
Q1 | $6.95M | Sell |
|
|||||
|
2024
Q4 | $6.45M | Sell |
|
|||||
|
2024
Q3 | $11.2M | Buy |
|
|||||
|
2024
Q2 | $7.52M | Buy |
|
|||||
|
2024
Q1 | $5.03M | Buy |
|
|||||
|
2023
Q4 | $4.51M | Buy |
|
|||||
|
2023
Q3 | $3.22M | Sell |
|
|||||
|
2023
Q2 | $3.69M | Buy |
|
|||||
|
2023
Q1 | $438K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $524K | Sell |
|
|||||
|
2022
Q2 | $605K | Sell |
|
|||||
|
2022
Q1 | $785K | Buy |
|
|||||
|
2021
Q4 | $560K | Sell |
|
|||||
|
2021
Q3 | $548K | Buy |
|
|||||
|
2021
Q2 | $508K | Buy |
|
|||||
|
2021
Q1 | $508K | Buy |
|
|||||
|
2020
Q4 | $421K | Sell |
|
|||||
|
2020
Q3 | $570K | Buy |
|
|||||
|
2020
Q2 | $561K | Buy |
|
|||||
|
2020
Q1 | $331K | Buy |
|
|||||
|
2019
Q4 | $249K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $222K | Buy |
|
|||||
|
2019
Q1 | $204K | Buy |
|
|||||
|
2018
Q4 | $84K | Buy |
|